Physical exercise helps to improve symptoms of Parkinson’s disease

Physical exercise - to include strength, resistance and endurance forms of exercise, as well as dance, tai chi, yoga and physiotherapy - can help to improve the severity of movement-related symptoms and quality of life in people with Parkinson’s disease, according to recent findings by Cochrane, a collaboration of independent, international experts led by Dr. Elke Kalbe, Professor of Medical Psychology at the University of Cologne, Germany.

According to Moritz Ernst, the first author of the review and member of Cochrane Hematology, "We observed clinically meaningful improvements in the severity of motor symptoms for most types of exercise. These included dancing, training to improve gait, balance and movement, multi-exercise training, and mind-body training." Click here to learn more.

Research opportunity for HD patients and caregivers

Rare Patient Voice (RPV) is recruiting patients and caregivers living in United States for an important Huntington's research opportunity. This is a 25-minute online survey, and the compensation is $50. Please sign up here to receive an e-mailed invitation to a screening survey to see if you qualify.

Rare Patient Voice connects patients and caregivers with the opportunity to voice their opinions through surveys and interviews to improve medical products and services, while earning cash rewards.

Focused ultrasound can improve Parkinson's symptoms for up to 1 year

A new study conducted at the University of Maryland Medical System presents a novel, noninvasive method using focused ultrasound to reduce involuntary movements, or dyskinesia, and motor impairment in people receiving treatment for Parkinson’s disease. The study appears in The New England Journal of Medicine.

At three months after undergoing the incisionless technique, twice as many people experienced an improvement in dyskinesia and motor impairment compared to study participants who received a sham, or placebo, treatment. The improvements lasted up to 1 year in 77% of those who responded to the treatment. Click here to learn more.

Double your donation through March 31

Now through March 31, Movement Disorders Foundation will match all contributions received - dollar for dollar up to $5000 - in our commitment to support the most promising translational research and treatments in movement disorders. We need your support to ensure we can continue finding, assessing and supporting today's most innovative undiscovered pioneers.

Double your impact for movement disorders research and education! Click here to support our efforts with your tax-deductible contribution during this special match.

Praxis Precision Medicines reports data from essential tremor therapy trial

Praxis Precision Medicines has reported topline data from the Phase IIb Essential1 trial of ulixacaltamide to treat essential tremor (ET). According to the findings, participants who received treatment with ulixacaltamide showed improvement in the modified Activities of Daily Living (mADL) score relative to the placebo. Click here to learn more.